Auffarth, Gerd U.
Schickhardt, Sonja K.
Fang, Hui
Wang, Qiang
Khoramnia, Ramin
Yildirim, Timur M.
Funding for this research was provided by:
Alcon Research Institute
Klaus Tschira Stiftung
Medizinischen Fakultät Heidelberg, Universität Heidelberg
Universitätsklinikum Heidelberg
Article History
Received: 22 January 2022
Accepted: 19 August 2022
First Online: 26 August 2022
Competing interests
: G. Auffarth reports grants, personal fees, non-financial support and consulting fees from Johnson&Johnson and Alcon, grants, personal fees and non-financial support from Carl Zeiss Meditec, Hoya, Kowa, Oculentis/Teleon, Rayner, Santen, Sifi, Ursapharm, grants and personal fees from Biotech, Oculus, EyeYon, grants from Acufocus, Anew, Contamac, Glaukos, Physiol, Rheacell. R. Khoramnia reports grants, personal fees and non-financial support from Alimera, Alcon, Bayer, Johnson&Johnson, Hoya, Novartis, Physiol, Rayner and Roche, grants from Chengdu Kanghong, personal fees and non-financial support from Allergan, Kowa, Oculentis/Teleon, Oculus, Santen, and Acufocus. S. Schickhardt, H. Fang and Q. Wang have nothing to disclose. T. Yildirim reports personal fees from Alcon.